Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-2.06 %
$ 25.4 M
Market Cap
-0.5
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Clene Inc.
| Revenue | 342 K |
| Cost Of Revenue | 70 K |
| Gross Profit | 272 K |
| Operating Expenses | 33.4 M |
| Operating Income | -33.1 M |
| Other Expenses | 6.31 M |
| Net Income | -39.4 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0.3 | 0.7 | 0.5 | 0.7 | 0.2 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 70 K | 0.1 | 26 K | 0.3 | 65 K | 0.9 | 0 | 0 |
| Gross Profit | 0.3 | 0.5 | 0.4 | 0.4 | 0.1 | (0.9) | 0 | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 33.4 | 41.1 | 45.8 | 45.7 | 17.1 | 15.7 | 0.3 | 2.39 K |
| Selling, General and Administrative Expenses | 12.3 | 14.4 | 16.9 | 18.8 | 5.2 | 6.8 | 0.3 | 2.39 K |
| Research and Development Expenses | 20.1 | 26.7 | 31.9 | 28.4 | 15.2 | 9.6 | 6.6 | 0 |
| Operating Income | (33.1) | (40.5) | (45.3) | (45.3) | (17.0) | (16.3) | (0.3) | 2.39 K |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 4.1 | 4.6 | 3.3 | 0.9 | 0.9 | 88 K | 0 | 0 |
| Total Other Income | (6.3) | (9.0) | 18.5 | 39.8 | 1.3 | 0.2 | 0.3 | 3 |
| Pre-Tax Income | (39.4) | (49.5) | (29.9) | (10.2) | (18.9) | (16.2) | 19.4 K | 2.39 K |
| NET INCOME | ||||||||
| Tax Provision | 0 | 0 | (14.6) | (0.4) | 0.4 | 0.1 | (0.4) | 0 |
| Net Income | (39.4) | (49.5) | (15.3) | (9.7) | (19.3) | (16.3) | (0.3) | 2.39 K |
| EPS | 5.67 | 9.43 | 4.69 | 3.16 | 5.51 | 4.69 | 0.0889 | 0.0008 |